Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects von Miller, Ian S., Khan, Sonja, Shiels, Liam P., Das, Sudipto, O' Farrell, Alice C., Connor, Kate, Lafferty, Adam, Moran, Bruce, Isella, Claudio, Loadman, Paul, Conroy, Emer, Cohrs, Susan, Schibli, Roger, Kerbel, Robert S., Gallagher, William M., Marangoni, Elisabetta, Bennett, Kathleen, O' Connor, Darran P., Dwyer, Róisín M., Byrne, Annette T.

Volltext

Breast cancer proteomics: clinical perspectives von Lau, Thomas YK, O'Connor, Darran P, Brennan, Donal J, Duffy, Michael J, Pennington, Stephen R, Gallagher, William M

Volltext

Functional interrogation of breast cancer: from models to drugs von McGee, Sharon F, O'Connor, Darran P, Gallagher, William M

Volltext

Abstract 1254: Mechanistic interrogation of pre-treatment low dose aspirin effects in HER 2 positive breast cancer von Miller, Ian S., Khan, Sonja, Shiels, Liam P., Das, Sudipto, Moran, Bruce, Leacy, Finbarr P., Loadman, Paul M., Kerbel, Robert S., Connor, Darran O', Bennett, Kathleen, Dwyer, Róisín M., Byrne, Annette T.

Volltext